Edges in Network
| Network | GSE25066_egf1520 - GSE25066 - SiGN-BN HC+Bootstrap |
| Network Description | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | FZD5 |
| Upstream (Parents) |
|---|
| (<<) ADCY3 → FZD5 |
| (<<) ARHGEF2 → FZD5 |
| (<<) ASNS → FZD5 |
| (<<) BMPR2 → FZD5 |
| (<<) BZW1 → FZD5 |
| (<<) CCDC88A → FZD5 |
| (<<) CHST12 → FZD5 |
| (<<) CISH → FZD5 |
| (<<) CSNK1E → FZD5 |
| (<<) DDX18 → FZD5 |
| (<<) EGFR → FZD5 |
| (<<) ELF5 → FZD5 |
| (<<) ELOVL1 → FZD5 |
| (<<) EPHB4 → FZD5 |
| (<<) ERBB2 → FZD5 |
| (<<) FADS2 → FZD5 |
| (<<) FZD7 → FZD5 |
| (<<) HLA-G → FZD5 |
| (<<) HSPA14 → FZD5 |
| (<<) HSPA5 → FZD5 |
| (<<) ITGA6 → FZD5 |
| (<<) ITGB5 → FZD5 |
| (<<) KCNN4 → FZD5 |
| (<<) KLF10 → FZD5 |
| (<<) MAPK13 → FZD5 |
| (<<) MYL5 → FZD5 |
| (<<) MYO1E → FZD5 |
| (<<) PLA2G12A → FZD5 |
| (<<) PODXL → FZD5 |
| (<<) PRPF4B → FZD5 |
| (<<) SALL2 → FZD5 |
| (<<) SHC2 → FZD5 |
| (<<) SLC6A14 → FZD5 |
| (<<) SMAD7 → FZD5 |
| (<<) SULT1A1 → FZD5 |
| (<<) TCOF1 → FZD5 |
| (<<) TGFB1 → FZD5 |
| (<<) TRIM32 → FZD5 |
| (<<) UBE2D3 → FZD5 |
| (<<) VCP → FZD5 |
| Downstream (Children) |
|---|
| FZD5 → ALPPL2 (>>) |
| FZD5 → CAT (>>) |
| FZD5 → CDKN1A (>>) |
| FZD5 → ENO2 (>>) |
| FZD5 → FGFR2 (>>) |
| FZD5 → HK2 (>>) |
| FZD5 → NEUROG3 (>>) |
| FZD5 → NFKBIB (>>) |
| FZD5 → PFKFB3 (>>) |
| FZD5 → PHLDA1 (>>) |
| FZD5 → PYGB (>>) |
| FZD5 → RBKS (>>) |
| FZD5 → TNFRSF11A (>>) |
